Live
CAC 40 · Healthcare ·

EssilorLuxottica (EL) shareholders approve €4.00 dividend, all AGM resolutions

EssilorLuxottica shareholders approved all 30 resolutions at the company's Annual General Meeting on April 28, 2026. Among the key decisions was the endorsement of a €4.00 per share dividend for the 2025 fiscal year, alongside the executive compensation policy. The French optical group's shares are trading down 0.5% at €179.70 on April 30, 2026.

The approved dividend offers shareholders the option to receive their final payout in newly issued shares. The subscription price for these new shares has been set at €175.06 per share, providing investors with flexibility as part of the company's 2025 financial year distribution policy.

This slight intraday movement follows a volatile week for EssilorLuxottica. The stock had already declined 3.2% on April 27, 2026, amid concerns over margin dilution. Despite the unanimous approval of the AGM resolutions, EssilorLuxottica's share price continues to exhibit modest downward pressure, trading at €179.70 after closing yesterday at €180.60.

What Does It Mean

Why Margin Concerns Are Weighing on EssilorLuxottica

EssilorLuxottica designs, manufactures, and distributes corrective lenses, eyeglass frames, and sunglasses. This global optics leader serves millions of people worldwide, generating revenue by selling these essential and luxury products for both vision correction and aesthetic purposes.

Today's slight dip in EssilorLuxottica's share price appears primarily linked to persistent investor concerns about future profitability and margin dilution. Even though the company's Annual General Meeting on 28 April 2026 approved all resolutions, including a €4.00 dividend for 2025 with an option for payment in new shares at €175.06, the market remains cautious. These worries had already led to a 3.2% decline in the stock on 27 April.

This investor caution is reflected in EssilorLuxottica's shares trading down 0.5% today, 30 April 2026, currently at €179.70, having closed yesterday at €180.60.

Think of a high-end fashion brand known for its exquisite craftsmanship. If the brand announces a new collection that's well-received, but simultaneously, there are whispers among industry insiders that the cost of their unique fabrics and skilled labour is rising significantly, customers might hesitate. Even with a desirable product, the expectation of lower profit per item could make buyers less confident in the brand's long-term value.

Tags

EssilorLuxottica

EL·Euronext Paris·CAC 40·🇫🇷
Industry
Medical - Instruments & Supplies
CEO
Francesco Milleri
Employees
153,498
Headquarters
Paris, FR
Listed
2000
About

EssilorLuxottica S.A. (EL) is a global leader in ophthalmic products, specialising in the design, manufacture, and distribution of lenses, frames, and sunglasses. Its operations span North America, Europe, Latin America, Asia, Oceania, and Africa, organised across five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The company's diverse portfolio includes well-known lens brands such as Varilux, Crizal, and Transitions, alongside optical instruments for professionals. Its Equipment division supplies digital surfacing and lens coating machines. The Sunglasses and Readers segment offers a wide array of non-prescription eyewear under various brands, including Foster Grant and Bolon. With a network of 490 prescription laboratories and edging-mounting facilities, EssilorLuxottica was founded in 1849 and is headquartered in Paris, France.